Business Wire

Hopin Acquires StreamYard, a Leading Live Video Streaming Studio, for $250 Million

7.1.2021 15:30:00 EET | Business Wire | Press release

Share

Hopin, a leading virtual events platform, announced today that it has acquired StreamYard, a live video streaming studio that allows content creators to produce professional-quality video streaming experiences. The purchase will allow Hopin to provide advanced video production features to Hopin event organizers. In addition to eventually integrating its features into the Hopin platform, StreamYard will continue to also offer its live streaming studio tools to independent content creators. Hopin will pay a total purchase consideration of $250 million to acquire StreamYard, comprised of cash and stock.

“When I founded Hopin, I wanted to replicate all the best aspects of physical events -- from one-on-one networking to exploring an expo -- and more. As Hopin became the go-to virtual venue for event organizers, the next product to add was professional-quality video production, so I’ve long had my eye on the advanced studio tools that StreamYard provides,” said Johnny Boufarhat, founder and CEO of Hopin. “StreamYard is the solution of choice for live streamers around the world because of its superior ease of use and great features. This acquisition fits in with our goal to build the best products that help people connect and communicate better through engaging online experiences. I can’t wait to make it available to all of our customers so they can uplevel their events and truly dazzle their attendees.”

“Live streamers love StreamYard for its ease of use, stability, and professional-quality streams and I am thrilled that we can now easily bring those three pillars to event organizers around the world,” said Geige Vandentop, co-founder and CEO, StreamYard. “We have been integrating with Hopin as a third-party broadcast solution for months and it just makes sense to officially join forces and combine our efforts. At StreamYard, we are now committed to serving the needs of content creators and event producers alike.”

StreamYard, based in Tualatin, Oregon, was founded in 2018 by Geige Vandentop and Dan Briggs. They were inspired by live streaming’s rapid growth in the gaming community, which ultimately allowed people to turn hobbies into careers. However, they recognized that live streaming production required expensive hardware and an understanding of complex technology, a considerable barrier for most businesses wanting to create compelling live content for their audiences. To solve this, they developed a streaming solution that was simple to use by anyone, but powerful enough to create professional-quality content. The two founders bootstrapped StreamYard and grew revenues to nearly $10 million in early 2020 before quickly hiring a team of 19 and reaching over $30 million in annual recurring revenue by year-end. Today, StreamYard serves over 100,000 paying customers, adding 10,000 paying customers per month, and powers millions of broadcasts every month with a diverse global user-base ranging from social media influencers to large corporations.

StreamYard is a cloud-based solution that works in any web browser to empower businesses, entertainers, hobbyists, nonprofits, and anyone with a message to create compelling live events for their audiences and simulcast live to a number of social channels, including YouTube, Facebook, LinkedIn, and Twitch. It allows creators to easily brand their broadcasts with themes, color schemes, overlays, backgrounds, logos, and even GIFs. They can also easily host up to ten live guests to interview at once, show on-screen comments from viewers, and add call-to-action interactions to increase conversions and sales.

Hopin and StreamYard will work together to help event organizers bring StreamYard’s compelling, engaging, and easy-to-use capabilities to their online gatherings. StreamYard will soon replace the Hopin Studio and power all Hopin Stages, with native integration expected in H1 2021. Hopin aims to accelerate StreamYard’s innovative product development, sales and marketing, and grow StreamYard’s enterprise customer base. Vandentop and Briggs will continue to oversee the StreamYard team of 19 employees, while joining Hopin to assist Boufarhat in building out the company’s overall vision as a one-stop-shop for the best video broadcasting services and virtual event experiences.

“Hopin is one of our most astounding growth stories; the team’s Series B in November was a momentous milestone in every respect, including for the fast-changing virtual events industry,” said Sonali De Rycker, partner at Accel. “And they’ve now acquired two companies—first Topi, and now StreamYard. To pull this off in the first year of operation is unprecedented. The combination with StreamYard is incredibly powerful and will further fuel Hopin’s trajectory as it charts the future of online experiences.”

Hopin continues to enjoy rapid growth and soaring demand since its launch in February 2020. It has scaled from 5,000 registered users and 1,800 organizations hosting events on the Hopin platform to more than 5 million users and over 100,000 organizations hosting events. Last year alone, the remote-first company grew from eight employees to nearly 300 across 38 countries. Hopin has raised over $170 million to date, most recently completing a $125 million Series B led by IVP and Tiger Global and joined by Coatue and DFJ Growth, along with Hopin’s returning investors Accel, Northzone, Salesforce Ventures, and Seedcamp.

About Hopin

Founded in 2019, Hopin is the first all-in-one live virtual events platform where attendees can learn, interact, and connect with people from anywhere in the world. With Hopin, you can create live virtual and hybrid events that are interactive and immersive. Whether you're hosting a live training workshop, bringing your company’s remote team together, or launching a full-scale annual conference, it’s easy to create an engaging event on Hopin for up to hundreds of thousands of people. Attendees can network one-on-one, break out into group sessions, watch keynote presentations, send chat messages and polls, and explore interactive expo areas. There’s also a virtual backstage for speakers and plenty of sponsorship opportunities. Hopin is a remote-first company based in London, with employees in 38 countries. Learn more at hopin.com.

About StreamYard

StreamYard provides a live video streaming studio that allows content creators to produce professional-quality streaming experiences. StreamYard’s cloud-based solution makes it easy to create graphically-rich branded experiences, host multiple guests at once, engage with viewers, and simulcast to multiple live streaming platforms, including YouTube, Facebook, LinkedIn, and Twitch. Founded in 2018, StreamYard is based in Tualatin, Oregon. For more information, visit streamyard.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Hopin
Niko Felix
niko@theoutcastagency.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye